BSE filing, NSE: BALAJITELE. Summary written from the filing by ALFA Finder's alert engine.
Balaji Telefilms Ltd: key numbers
- Share price
- ₹85.00
- Market cap
- ₹1,036 Cr
- Revenue (annual)
- ₹210.8 Cr
- Net profit (annual)
- ₹-49.10 Cr
- P/E (TTM)
- -49.6×Sector 28.6×
- Promoter holding
- 31.30%+0.00% QoQ
- FII holding
- 24.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balaji Telefilms Ltd
All →Balaji Telefilms Employee Stock Options
Balaji Telefilms granted 10,20,000 ESOP options to employees at ₹62.86 exercise price. Options vest after 12 months with a 3-year exercise window.
Balaji Telefilms Board Meeting Date
Balaji Telefilms has scheduled a board meeting on 13-Nov-2026 to consider Q2 FY27 unaudited results. The trading window is closed until 16-Nov-2026.
Balaji Telefilms Annual General Meeting
Balaji Telefilms filed minutes of its 32nd AGM held September 29, 2026. Routine approvals included re-appointment of MD by rotation and adoption of FY26 financials.
Balaji Telefilms Other Announcement
Balaji Telefilms approved the continued directorship of Ms. Priyanka Chaudhary and fixed remuneration for the Managing Director and Joint Managing Director for their remaining tenures.
Balaji Telefilms Management Change
Balaji Telefilms approved the remuneration for its Managing Director and Joint Managing Director, and the continuation of directorship for Ms. Priyanka Chaudhary.
Balaji Telefilms Annual General Meeting
Balaji Telefilms Limited held its 32nd Annual General Meeting on September 29, 2026. The meeting covered adoption of financial statements and re-appointment of directors.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.